Answers are grounded in this paper and cite their sources.
Retrospective study reveals distinct remission and survival predictors for venetoclax therapy in acute myeloid leukemia, highlighting a novel model to estimate early response.
Treatment response, survival outcomes, and factors related to venetoclax (VEN)-based therapy were assessed in patients with acute myeloid leukemia (AML), including newly diagnosed AML (ND-AML) and relapsed/refractory AML (R/R AML). We also developed a model to predict composite complete remission (CRc) after the first treatment cycle. This retrospective study included 216 patients with AML who received VEN-based regimens at the First Hospital of Lanzhou University between March 2020 and May 2025. Treatment response, overall survival (OS), and factors related to CRc and OS were evaluated. A multivariable model for CRc was developed and internally validated using 1,000 bootstrap resamples. Of the 216 patients, 165 had ND-AML and 51 had R/R AML. CRc was achieved in 74.5% and 39.2% of patients, respectively. In ND-AML, failure to achieve CRc, older age, and NF1 mutation were independently associated with shorter OS. In R/R AML, a lower pretreatment white blood cell count and a higher bone marrow blast percentage were associated with CRc, whereas failure to achieve CRc was associated with higher mortality. The final six-predictor model included AML status, age, bone marrow blast percentage, platelet count, Eastern Cooperative Oncology Group (ECOG) performance status, and TET2 mutation. Its apparent area under the receiver operating characteristic curve (AUC) was 0.841 (95% confidence interval, 0.785–0.897). The fixed CRc score yielded time-dependent OS AUCs of 0.788 at 6 months and 0.695 at 12 months. The model may be useful for estimating early treatment response, although external validation is needed before routine clinical application.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: